Notch signaling mutations increase intra-tumor chemokine expression and predict response to immunotherapy in colorectal cancer

The Notch signaling mutation is associated with enhanced anti-tumor immune response in colorectal cancer (CRC). In this study, we aim to investigate the underlying mechanism and the predictive potential of Notch signaling mutation for responding to immunotherapy in CRC.